Back to results
US 2026/0008792 A1Published application
Processes and compounds
AssigneeRadius Pharmaceuticals, Inc.
InventorMichael MARKEY
Life of this patent
Estimating the term…
Abstract
Useful processes of preparation and intermediates useful for the preparation of Compound 1, a selective estrogen receptor alpha (ERα) modulator/degrader (SERM/SERD), having utility for the treatment of ER+ cancers including breast cancer are described.
Claims15
A compound selected from (a), (b), (e), (f), and (g)
10-65. (canceled)
Dependencies are inferred from the claim text.